Track topics on Twitter Track topics that are important to you
Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) und Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx) gaben Read more...
Tokyo, Japan, May 30, 2018 –Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and COO: Masashi Miyamoto, “Kyowa Hakko Kirin”) announced today that it has been notified that the U.S. Food and Dr...
NOVATO, Calif. and TOKYO and LONDON, May 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products fo...
Kyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance ReportSummaryKyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and i...
NOVATO, Calif. and TOKYO and LONDON, April 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel produ...
TOKYO, Aug. 8, 2018 /PRNewswire/ — Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Poteligeo® (mogamulizumab...
USA-based Aevi Genomic Medicine has expanded its collaboration with Japan’s Kyowa Hakko Kirin with…
Japan-based Kyowa Hakko Kirin has reported positive results from the Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL (MAVORIC) study after...Read More... The post Kyowa Kirin reports positi...
Burosumab (Crysvita; Kyowa Hakko Kirin Co., Ltd. and Ultragenyx Pharmaceutical Inc.) is a fully human monoclonal antibody directed at fibroblast growth factor 23 (FGF23). Excessive FGF23 production ha...
From its foundation in 1949, Kyowa Hakko has been a global leader in the pharmaceutical industry. Today, Kyowa's expertise extends to the United States through Kyowa Pharmaceutical, Inc. headquartered...
We have published hundreds of Kyowa Hakko Kirin Co. Ltd. news stories on BioPortfolio along with dozens of Kyowa Hakko Kirin Co. Ltd. Clinical Trials and PubMed Articles about Kyowa Hakko Kirin Co. Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kyowa Hakko Kirin Co. Ltd. Companies in our database. You can also find out about relevant Kyowa Hakko Kirin Co. Ltd. Drugs and Medications on this site too.